What is the average price target for Credit Suisse Group (CS) stock?
23 analysts have analysed CS and the average price target is 1.51 USD. This implies a price increase of 70.83% is expected in the next year compared to the current price of 0.8858.
NYSE:CS • US2254011081
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for Credit Suisse Group (CS).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2023-02-16 | Citigroup | Downgrade | Buy -> Neutral |
| 2021-11-05 | Deutsche Bank | Downgrade | Buy -> Hold |
| 2021-10-19 | Kepler Cheuvreux | Upgrade | Hold -> Buy |
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 22.389B -0.42% | 22.696B 1.37% | 14.921B -34.26% | 14.612B -2.07% | 15.252B 4.38% | 15.633B 2.50% | 16.887B 8.02% | 17.426B 3.19% | |
| EBITDA YoY % growth | N/A | N/A | N/A -118.94% | -3.455B -144.34% | -1.751B 49.33% | -156.385M 91.07% | N/A | N/A | |
| EBIT YoY % growth | N/A 4.66% | N/A 13.35% | N/A -158.51% | -2.732B 13.94% | -1.741B 36.27% | 137.84M 107.92% | N/A | N/A | |
| Operating Margin | N/A | N/A | N/A | -18.70% | -11.42% | 0.88% | N/A | N/A | |
| EPS YoY % growth | 1.02 -20.45% | 1.36 33.33% | -2.63 -294.00% | -0.47 82.20% | -0.11 75.53% | 0.22 288.66% | 0.33 54.07% | 0.37 12.13% |
All data in CHF
| Q2 / 23 | Q3 / 23 | Q4 / 23 | |
|---|---|---|---|
| EPS Q2Q % growth | -0.18 69.47% | -0.14 90.84% | 0.19 139.91% |
| Revenue Q2Q % growth | N/A | N/A | N/A |
| EBITDA Q2Q % growth | N/A | N/A | N/A |
| EBIT Q2Q % growth | N/A | N/A | N/A |
All data in CHF
23 analysts have analysed CS and the average price target is 1.51 USD. This implies a price increase of 70.83% is expected in the next year compared to the current price of 0.8858.
Credit Suisse Group (CS) will report earnings on 2023-07-27, before the market open.
The consensus rating for Credit Suisse Group (CS) is 46.087 / 100 . This indicates that analysts generally have a neutral outlook on the stock.